BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 21993050)

  • 21. Comparison of the NAL(R) and Cambridge formulae for the fitting of linear hearing aids.
    Peters RW; Moore BC; Glasberg BR; Stone MA
    Br J Audiol; 2000 Feb; 34(1):21-36. PubMed ID: 10759075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Task-Dependent Effects of Signal Audibility for Processing Speech: Comparing Performance With NAL-NL2 and DSL v5 Hearing Aid Prescriptions at Threshold and at Suprathreshold Levels in 9- to 17-Year-Olds With Hearing Loss.
    Pittman AL; Stewart EC
    Trends Hear; 2023; 27():23312165231177509. PubMed ID: 37254534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAL-NL2 empirical adjustments.
    Keidser G; Dillon H; Carter L; O'Brien A
    Trends Amplif; 2012 Dec; 16(4):211-23. PubMed ID: 23203416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximizing effective audibility in hearing aid fitting.
    Ching TY; Dillon H; Katsch R; Byrne D
    Ear Hear; 2001 Jun; 22(3):212-24. PubMed ID: 11409857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of multi-channel compression time constants on subjectively perceived sound quality and speech intelligibility.
    Hansen M
    Ear Hear; 2002 Aug; 23(4):369-80. PubMed ID: 12195179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Different Hearing Aid Prescriptions for Children.
    Marriage JE; Vickers DA; Baer T; Glasberg BR; Moore BCJ
    Ear Hear; 2018; 39(1):20-31. PubMed ID: 28691934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAL-NL1 procedure for fitting nonlinear hearing aids: characteristics and comparisons with other procedures.
    Byrne D; Dillon H; Ching T; Katsch R; Keidser G
    J Am Acad Audiol; 2001 Jan; 12(1):37-51. PubMed ID: 11214977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preferred number of channels (one, two, or four) in NAL-NL1 prescribed wide dynamic range compression (WDRC) devices.
    Keidser G; Grant F
    Ear Hear; 2001 Dec; 22(6):516-27. PubMed ID: 11770673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of real-ear insertion gains in Japanese-speaking individuals wearing hearing aids with DSLv5 and NAL-NL2.
    Furuki S; Sano H; Kurioka T; Ogiwara A; Nakagawa T; Inoue R; Umehara S; Hara Y; Suzuki K; Yamashita T
    Auris Nasus Larynx; 2021 Feb; 48(1):75-81. PubMed ID: 32747167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescriptive amplification recommendations for hearing losses with a conductive component and their impact on the required maximum power output: an update with accompanying clinical explanation.
    Johnson EE
    J Am Acad Audiol; 2013 Jun; 24(6):452-60. PubMed ID: 23886423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-Adjustment of Hearing Aid Amplification for Lower Speech Levels: Independent Ratings, Paired Comparisons, and Speech Recognition.
    Perry TT; Nelson PB
    Am J Audiol; 2022 Jun; 31(2):305-321. PubMed ID: 35316099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fitting recommendations and clinical benefit associated with use of the NAL-NL2 hearing-aid prescription in Nucleus cochlear implant recipients.
    English R; Plant K; Maciejczyk M; Cowan R
    Int J Audiol; 2016; 55 Suppl 2():S45-50. PubMed ID: 26853233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of the NAL-NL2 and DSL v5.0a prescription procedures in the adaptation of hearing aids in the elderly.
    Bertozzo MC; Blasca WQ
    Codas; 2019 Aug; 31(4):e20180171. PubMed ID: 31433039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a loudness model for hearing-aid fitting. I. Linear hearing aids.
    Moore BC; Glasberg BR
    Br J Audiol; 1998 Oct; 32(5):317-35. PubMed ID: 9845030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using trainable hearing aids to examine real-world preferred gain.
    Mueller HG; Hornsby BW; Weber JE
    J Am Acad Audiol; 2008; 19(10):758-73. PubMed ID: 19358456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of hearing aid provision for severe hearing loss].
    Engler M; Digeser F; Hoppe U
    HNO; 2022 Jul; 70(7):520-532. PubMed ID: 35061063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Hearing Aid Manufacturers' Software-Derived Fittings to DSL v5.0 Pediatric Targets.
    Folkeard P; Bagatto M; Scollie S
    J Am Acad Audiol; 2020 May; 31(5):354-362. PubMed ID: 31639078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Patient-Centered, Provider-Facilitated Approach to the Refinement of Nonlinear Frequency Compression Parameters Based on Subjective Preference Ratings of Amplified Sound Quality.
    Johnson EE; Light KC
    J Am Acad Audiol; 2015 Sep; 26(8):689-702. PubMed ID: 26333877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of Extended Bandwidth Hearing Aid Amplification on Speech Intelligibility and Sound Quality in Adults with Mild-to-Moderate Hearing Loss.
    Seeto A; Searchfield GD
    J Am Acad Audiol; 2018 Mar; 29(3):243-254. PubMed ID: 29488874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferred listening levels of children who use hearing aids: comparison to prescriptive targets.
    Scollie SD; Seewald RC; Moodie KS; Dekok K
    J Am Acad Audiol; 2000 Apr; 11(4):230-8. PubMed ID: 10783926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.